← Back
$VRTX All transactions

VERTEX PHARMACEUTICALS INC / MA

▼ SELL 10b5-1 Plan

$ Value

$560K

Shares

1,182

Price

$474

Filed

Feb 19

Insider

Name

Bunnage Mark E.

Title

EVP, Chief Scientific Officer

CIK

0002100735

Roles

Officer

Transaction Details

Transaction Date

2026-02-18

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

8,486

Footnotes

Restricted stock unit award that vests in installments beginning on February 20, 2027. | Transaction made pursuant to Dr. Bunnage's company approved trading plan under Rule 10b5-1, which was entered into on 11/26/2025.

Filing Info

Accession No.

0000875320-26-000088

Form Type

4

Issuer CIK

0000875320

Bunnage Mark E.'s History

Date Ticker Type Value
2026-02-25 VRTX $302K
2026-02-24 VRTX F $282K
2026-02-18 VRTX $560K
2026-02-17 VRTX A $0
2026-02-17 VRTX F $537K
2026-02-17 VRTX $1.2M
2026-02-13 VRTX F $1.1M
2026-02-11 VRTX $931K
2026-02-10 VRTX F $528K

Other Insiders at VRTX (90d)

Insider Bought Sold Last
SACHS BRUCE I 2026-04-15
WAGNER CHARLES F JR
EVP, CO & FO
2026-02-24
LEIDEN JEFFREY M
Executive Chairman
2026-02-24
Garber Alan M 2026-04-15
Sachdev Amit
EVP Chief Patient & Ext Af Off
$28.4M 2026-02-25
Upadhyay Suketu 2026-04-15
ALTSHULER DAVID
EVP, Chief Scientific Officer
2026-01-22
Bhatia Sangeeta N. $133K 2026-02-13
Kewalramani Reshma
CEO & President
2026-02-24
Biller Jonathan
EVP and Chief Legal Officer
$3.6M 2026-02-25
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
$1.6M 2026-02-25
Bozic Carmen
EVP and CMO
$2.2M 2026-03-27
Liu Joy
EVP and Chief Legal Officer
$439K 2026-04-01
Ambrose Kristen
SVP & Chief Accounting Officer
$2.0M 2026-02-26
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
$2.5M 2026-02-25
McKechnie Duncan
EVP, Chief Commercial Officer
$2.4M 2026-02-25
Bunnage Mark E.
EVP, Chief Scientific Officer
$2.4M 2026-02-25